About this item
Removal of any preexisting structures in lyophilized stocks of Aβ-peptide is the critical initial step for controlled aggregation studies. HFIP has been shown to break down β-sheet structure, disrupt hydrophobic forces in aggregated amyloid preparations, and promotes α-helical secondary structure. HFIP treatment of lyophilized Aβ-peptide resulted in a dense, homogeneous preparation of unaggregated peptide and samples can be stored as peptide films.
- Peptide Content: ≥ 60%
Some Products May Appear Restricted
To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.
If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)
If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation; additional documentation will be requested for these items prior to shipment.
Specifications
- Conjugation:Unconjugated
- Species:Human
- Storage Conditions:–20 °C
- Protein Synonyms:beta amyloid (1-40) HFIP|abeta (1-40) HFIP|amyloid 1-40 HFIP|amyloid beta (1-40) HFIP
- Protein/Peptide Name:beta-Amyloid (1-40) HFIP
- Purity:95%
- Molecular Weight:4329.9 Da
- Sequence:DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV